Correlation Between Veracyte and Evofem Biosciences
Can any of the company-specific risk be diversified away by investing in both Veracyte and Evofem Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Evofem Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Evofem Biosciences, you can compare the effects of market volatilities on Veracyte and Evofem Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Evofem Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Evofem Biosciences.
Diversification Opportunities for Veracyte and Evofem Biosciences
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Veracyte and Evofem is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Evofem Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evofem Biosciences and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Evofem Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evofem Biosciences has no effect on the direction of Veracyte i.e., Veracyte and Evofem Biosciences go up and down completely randomly.
Pair Corralation between Veracyte and Evofem Biosciences
If you would invest (100.00) in Evofem Biosciences on December 29, 2024 and sell it today you would earn a total of 100.00 from holding Evofem Biosciences or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Veracyte vs. Evofem Biosciences
Performance |
Timeline |
Veracyte |
Evofem Biosciences |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Veracyte and Evofem Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Veracyte and Evofem Biosciences
The main advantage of trading using opposite Veracyte and Evofem Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Evofem Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evofem Biosciences will offset losses from the drop in Evofem Biosciences' long position.Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
Evofem Biosciences vs. Tonix Pharmaceuticals Holding | Evofem Biosciences vs. Sonnet Biotherapeutics Holdings | Evofem Biosciences vs. Palisade Bio | Evofem Biosciences vs. iBio, Common Stock |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |